Anticoagulation Therapy in Patients with Non-valvular Atrial Fibrillation in a Private Setting in Brazil: A Real-World Study.
Pedro Gabriel Melo de Barros E SilvaHenry SznejderRafael VasconcellosGeorgette M CharlesHugo Tannus F Mendonca-FilhoJack MardekianRodrigo NascimentoStephen DukaczManuela Di FuscoPublished in: Arquivos brasileiros de cardiologia (2020)
More than 60% of the patients were below the desired target and the associated costs were higher.
Keyphrases
- atrial fibrillation
- end stage renal disease
- ejection fraction
- oral anticoagulants
- chronic kidney disease
- newly diagnosed
- healthcare
- catheter ablation
- left atrial
- venous thromboembolism
- direct oral anticoagulants
- left atrial appendage
- prognostic factors
- health insurance
- aortic valve
- coronary artery disease
- acute coronary syndrome